We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+11.94%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.73B
AUM Growth
+$6.46M
Cap. Flow
-$42.8M
Cap. Flow %
-2.48%
Top 10 Hldgs %
30.81%
Holding
279
New
77
Increased
40
Reduced
47
Closed
83

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$14.4M
2
ILMN icon
Illumina
ILMN
+$11.2M
3
ICUI icon
ICU Medical
ICUI
+$10.4M
4
OLK
Olink Holding AB (publ) American Depositary Shares
OLK
+$9.5M
5
OM icon
Outset Medical
OM
+$8.23M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$20.5M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$13.9M
3
LUNG icon
Pulmonx
LUNG
+$10.1M
4
NSTG
NanoString Technologies, Inc.
NSTG
+$9.8M
5
EVH icon
Evolent Health
EVH
+$7.06M

Sector Composition

Rank Sector Weight
1 Healthcare 34.81%
2 Industrials 0.32%
3 Materials 0.15%
4 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OEF icon
1
PUT
iShares S&P 100 ETF
OEF
$20.6B
$99M 5.73%
600,000
-100,000
-14% -$18.2M
BIIB icon
2
CALL
Biogen
BIIB
$30.7B
$59.5M 3.45%
223,000
-125,900
-36% -$26.7M
ESTA icon
3
Establishment Labs
ESTA
$2.28B
$52.2M 3.02%
956,745
-31,968
-3% -$1.91M
VRAY
4
DELISTED
ViewRay, Inc.
VRAY
$49.7M 2.88%
13,664,939
-204,169
-1% -$685K
FXD icon
5
PUT
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$276M
$48.6M 2.81%
500,000
+170,000
+52% +$8.19M
XNTK icon
6
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.23B
$47.6M 2.75%
600,000
+100,000
+20% +$10.9M
ILCV icon
7
PUT
iShares Morningstar Value ETF
ILCV
$1.35B
$47.2M 2.73%
1,000,000
-150,000
-13% -$9.36M
CUTR
8
DELISTED
Cutera, Inc.
CUTR
$46.4M 2.69%
1,018,619
-99,539
-9% -$4.54M
SPY icon
9
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$44.6M 2.58%
+125,000
New +$49.6M
GKOS icon
10
Glaukos
GKOS
$10.6B
$37.5M 2.17%
704,412
-92,188
-12% -$4.76M
INSP icon
11
Inspire Medical Systems
INSP
$1.74B
$35.8M 2.07%
201,584
-2,881
-1% -$579K
LIVN icon
12
CALL
LivaNova
LIVN
$4.2B
$34.5M 2%
680,100
-189,000
-22% -$11.2M
QQQ icon
13
PUT
Invesco QQQ Trust
QQQ
$484B
$33.4M 1.93%
+125,000
New +$37.7M
GKOS icon
14
CALL
Glaukos
GKOS
$10.6B
$32.5M 1.88%
610,000
+480,000
+369% +$24.8M
GH icon
15
CALL
Guardant Health
GH
$22.6B
$30.7M 1.78%
570,000
+105,000
+23% +$5.39M
UNH icon
16
PUT
UnitedHealth
UNH
$370B
$30.3M 1.75%
+60,000
New +$31.5M
GDX icon
17
PUT
VanEck Gold Miners ETF
GDX
$27.4B
$26.9M 1.56%
400,000
+100,000
+33% +$2.53M
UTHR icon
18
United Therapeutics
UTHR
$23.1B
$26.2M 1.51%
125,046
+64,396
+106% +$14.4M
STAA icon
19
PUT
STAAR Surgical
STAA
$1.21B
$26.1M 1.51%
+370,000
New +$31.7M
SRPT icon
20
CALL
Sarepta Therapeutics
SRPT
$1.77B
$22.1M 1.28%
200,000
– –
MTD icon
21
PUT
Mettler-Toledo International
MTD
$28.6B
$21.7M 1.25%
20,000
+2,500
+14% +$3.11M
GH icon
22
Guardant Health
GH
$22.6B
$21.6M 1.25%
400,984
-68,508
-15% -$3.52M
GH icon
23
PUT
Guardant Health
GH
$22.6B
$21.5M 1.25%
400,000
+330,000
+471% +$16.9M
DENT
24
CALL
DELISTED
AdvisorShares Dent Tactical ETF
DENT
$20.1M 1.16%
+2,254,700
New +$20.1M
ICUI icon
25
CALL
ICU Medical
ICUI
$4.61B
$18.8M 1.09%
+125,000
New +$20.8M
1
2 3 4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
ONGA
O'Neil Global Advisors Los Angeles, California $14.4M AUM 220.73% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SR
Swiss Re Zurich, Switzerland $16.4M AUM
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM

Pura Vida Investments's Q3 2022 Portfolio in Review

As of Q3 2022, Pura Vida Investments held 279 positions worth $1.73B, up 0.38% from $1.72B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Pura Vida Investments's Q3 2022 filing shows 77 new, 40 increased, 47 reduced and 83 closed positions. Its largest new stake was Illumina: 56,540 shares worth $10.5M. The largest sale was Biogen, an estimated $20.5M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Industrials and Materials.

  • Pura Vida Investments's largest Q3 2022 buy was Illumina: 56,540 shares worth $10.5M.
  • Pura Vida Investments added most to United Therapeutics in Q3 2022, an estimated $14.4M increase.
  • Pura Vida Investments's biggest Q3 2022 reduction was Biogen, cutting an estimated $20.5M.
  • Pura Vida Investments fully exited Alnylam Pharmaceuticals in Q3 2022, selling an estimated $13.9M.
  • Pura Vida Investments's ten largest holdings make up 31% of its $1.73B portfolio in Q3 2022.
  • Pura Vida Investments opened 77 new positions and closed 83 in Q3 2022.
  • Pura Vida Investments's portfolio value rose 0.38% quarter-over-quarter to $1.73B.

Based on Pura Vida Investments's 13F filing for Q3 2022, filed 14 Nov 2022.